SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Suresh, M. Pazianas, B. Abrahamsen, Safety issues with bisphosphonate therapy for osteoporosis, Rheumatology, 2014, 53, 1, 19

    CrossRef

  2. 2
    Gad Rennert, Hedy S. Rennert, Mila Pinchev, Ofer Lavie, The effect of bisphosphonates on the risk of endometrial and ovarian malignancies, Gynecologic Oncology, 2014, 133, 2, 309

    CrossRef

  3. 3
    Naomi Gronich, Gad Rennert, Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates, Nature Reviews Clinical Oncology, 2013, 10, 11, 625

    CrossRef

  4. 4
    K. Sun, J. M. Liu, H. X. Sun, N. Lu, G. Ning, Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies, Osteoporosis International, 2013, 24, 1, 279

    CrossRef

  5. 5
    Stefanos Bonovas, Georgios Nikolopoulos, Pantelis Bagos, Bisphosphonate use and risk of colorectal cancer: a systematic review and meta-analysis, British Journal of Clinical Pharmacology, 2013, 76, 3
  6. 6
    Siddharth Singh, Abha Goyal Singh, Mohammad Hassan Murad, Paul J. Limburg, Bisphosphonates Are Associated With Reduced Risk of Colorectal Cancer: A Systematic Review and Meta-analysis, Clinical Gastroenterology and Hepatology, 2013, 11, 3, 232

    CrossRef

  7. 7
    Y. Chen, X. Yang, K. Meng, Z. Zeng, B. Ma, X. Liu, B. Qi, S. Cui, P. Cao, Y. Yang, Stress-Induced Hyperglycemia After Hip Fracture and the Increased Risk of Acute Myocardial Infarction in Nondiabetic Patients, Diabetes Care, 2013, 36, 10, 3328

    CrossRef

  8. You have free access to this content8
    J. Andrici, M. Tio, G. D. Eslick, Meta-analysis: oral bisphosphonates and the risk of oesophageal cancer, Alimentary Pharmacology & Therapeutics, 2012, 36, 8